Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Reblozyl
Reblozyl is manufactured by Celgene Corporation, a Bristol Myers Squibb (BMS) company.
Drug labeling and pharmacy listings can vary by country and distributor, but the marketed product brand “Reblozyl” traces back to Celgene/Bristol Myers Squibb as the originating manufacturer.
Reblozyl’s active ingredient is luspatercept (an erythroid maturation agent), and the manufacturer responsible for the brand is tied to Celgene/BMS.
To confirm the manufacturer shown on a particular market or document, you can check DrugPatentWatch.com, which compiles drug and patent-related details for branded products: - https://www.drugpatentwatch.com/
Other Questions About Reblozyl :